90 related articles for article (PubMed ID: 2141162)
1. [Isolation of coagulase-negative teicoplanin-resistant staphylococci].
Riegel P; Ellis A; Jehl F
Presse Med; 1990 Jun; 19(22):1053. PubMed ID: 2141162
[No Abstract] [Full Text] [Related]
2. Teicoplanin-resistant coagulase-negative staphylococci.
Arioli V; Pallanza R
Lancet; 1987 Jan; 1(8523):39. PubMed ID: 2879112
[No Abstract] [Full Text] [Related]
3. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.
Battista C; Panza N; Chiurazzi B; Romano A; Pacilio G; Amato G; Gargiulo F; Bolletti Censi M; Bocchetti M
Biomed Pharmacother; 1991; 45(1):43. PubMed ID: 1828377
[No Abstract] [Full Text] [Related]
5. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
6. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
Felmingham D; Solomonides K; O'Hare MD; Wilson AP; Grüneberg RN
J Antimicrob Chemother; 1987 Oct; 20(4):609-10. PubMed ID: 2960645
[No Abstract] [Full Text] [Related]
7. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
Kayaokay Y; Hasçelik G; Gür D; Akalin E
Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
[TBL] [Abstract][Full Text] [Related]
8. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
Goldstein FW; Coutrot A; Sieffer A; Acar JF
Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
10. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin-resistant coagulase-negative staphylococci.
Brumeitt W; Hamilton-Miller JM; Neville LO
Lancet; 1987 Feb; 1(8528):328. PubMed ID: 2880140
[No Abstract] [Full Text] [Related]
12. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients.
Maugein J; Pellegrin JL; Brossard G; Fourche J; Leng B; Reiffers J
Antimicrob Agents Chemother; 1990 May; 34(5):901-3. PubMed ID: 2141781
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
Greenwood D; Bidgood K; Turner M
J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
[TBL] [Abstract][Full Text] [Related]
15. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
Aubert G; Passot S; Lucht F; Dorche G
J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
[No Abstract] [Full Text] [Related]
16. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
17. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
18. Teicoplanin-resistant coagulase-negative staphylococcus.
Wilson AP; O'Hare MD; Felmingham D; Grüneberg RN
Lancet; 1986 Oct; 2(8513):973. PubMed ID: 2877149
[No Abstract] [Full Text] [Related]
19. Microbiological properties of teicoplanin.
Greenwood D
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
[TBL] [Abstract][Full Text] [Related]
20. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.
Moore EP; Speller DC
J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
